Newsletter Subject

How to Not Kill Grandma This Thanksgiving and Holiday Season

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Nov 25, 2023 12:15 PM

Email Preheader Text

Weekly Review Saturday, November 25, 2023 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT

[MEDPAGE TODAY]( Weekly Review Saturday, November 25, 2023 [How to Not Kill Grandma This Thanksgiving and Holiday Season]( [Live Shingles Vaccine and Waning Immunity; Semaglutide and CV Events]( [Infertility Linked With Small Autism Risk]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Advancing cTTP Care Through Integration of the Latest Clinical Evidence]( [A Medical Student, a Dying JFK, and ‘Destiny’: What a Young Doctor Saw 60 Years Ago]( [Plastic Surgeon Jailed for Patient Death; Oncologist Sues NYU; NP Sex Abuse Charges]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [Your SAD Patients May Not Understand Why They Feel Depressed]( CME SPOTLIGHT [Hitting the Mark? Targeted Antibody-Based Therapy for Diffuse Large B-Cell Lymphoma]( [Urgent Care Must Be Reexamined ... Urgently]( [Proteins Predict Signs of Alzheimer's Disease]( [What to Know About Ongoing Eye Drop Recalls]( CME SPOTLIGHT [Amplifying New and Emerging Clinical Evidence in the Treatment and Management of Myelodysplastic Syndrome]( [Doctors, Scientists Boycott Journal for Publishing 'Sadistic' Animal Research]( [Wondering Which Specialty to Choose? Consider This]( [Travel Nurse Practitioner Goes Missing in California]( CME SPOTLIGHT [Individualizing Advanced/Metastatic HER2+ Breast Cancer Care: Evidence-Based and Patient-Centered Approaches]( [Alzheimer's Vaccines Are Back; Streamlining Prior Authorization; Rare APOE Variant]( [Why It's So Tough to Reduce Unnecessary Medical Care]( [Proposed Methadone Treatment Legislation May Put Patients at Risk]( CME SPOTLIGHT [Bladder Cancer: Assessing and Incorporating Novel Treatment Strategies]( [Outcry Grows Over Pennsylvania Child Abuse Pediatrics Program]( [Positive KarXT Blood Pressure Data; ADHD Manufacturing Cover-Up? 'Profound Autism']( [OCEANIC-AF Trial Sunk; Second Renal Denervation Device Approved; Strep-Stroke Link?]( CME SPOTLIGHT [Elevating Care Coordination for Timely Management of Follicular Lymphoma]( [Cancer Patient's Final Act: Destroying Medical Debt]( ['Pharmageddon': The Pharmacy Labor Crisis]( [Longer Use of ADHD Meds May Boost Heart Risk]( CME SPOTLIGHT [Unlocking the Power of PARP Inhibition in Metastatic Castration-Resistant Prostate Cancer]( [China Reports No 'Unusual' Pathogens Driving Pneumonia Cluster in Kids]( [Osteoporosis and Oral Health]( [What's Going on at Mission Health?]( CME SPOTLIGHT [Clinical Case Challenge: Evidence-based Treatment Sequencing for BRAF Wild-type Metastatic Melanoma]( [I Love Being the 'ER Dad']( ['They Don't Play by Our Rules': What We Heard This Week]( [Compensation Is Key to Fixing Primary Care Shortage]( [How to Survive an EHR Upgrade]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2023-11-25&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.